Ethan Frome - Università degli studi di Pavia

GIOVANNI RICEVUTI, M.D.
ADDRESS: Divisione di Geriatria - ASP - IDR S.Margherita - Via Emilia 12 - 27100 Pavia - Italy
E-MAIL: <[email protected]> <[email protected]>
PHONE +390382381273 - +390382984110 - +390382984109 - +390382984107 FAX +39/0382465447 (segreteria)
CURRENT POSITION: Full Professor of Internal Medicine – Geriatrics – Emergency Medicine, Chief of the
Division of Geriatrics of the University of Pavia.
CURRICULUM VITAE
Born in Pavia, Italy, 26.10.1946, Dr. Ricevuti obtained a First Class Degree, together
the Lepetit prize from the University of Pavia in 1971. He was first fellow of C.E.C.A
European Community Foundation at the Institut of Humam Physiolgy of the same
University, Assistant Professor in 1972/73 at Geriatric Clinic, Fellow for Research and
University Researcher until 1984, Associate Professor of Medical Therapeutics from
1984 and Full Professor of Internal Medicine from academic year 2000/2001 at the
University of Pavia. He is at present the Chief of Geriatric Clinic of the University of
Pavia at ASP Pavia, IDR S.Margherita Hospital, in Pavia. He is teacher of Geriatric
Medicine, Medical Therapeutics and Emergency Medicine for the students of Medicine
and Nurse School and of some Postgraduated Specializations of the University of Pavia,
and Immunology and Physiopathology to students of Postgraduated Course in
Laboratory Technician. He is the Chief of the High School (Specialization) in Emergecy Medicine of the
University of Pavia. He is Responsible for the International Affairs of the Faculty of Medicine and ERASMUS
Project and for the international exchanges of the Faculty of Medicine and Surgery of the University of Pavia.
In this role he organized the first international trilateral project involving the Universities of
Pavia (Italy), Zaragoza (Spain) and Bordeaux (France) for an experimental Trilateral Medical
Degree in Medicine and Surgery, and enlarged the partnerships of the Medical Faculty of the
University of Pavia and the number of the students involved in these exchanges. In addition
Prof Ricevuti participated (2000-2007) in the European Projects ECTS and MEDINE 1 (Thematic
Network on Medical Education in Europe), and he is the delegate of the Medical Faculty of the
University of Pavia for the activities of the European MEDINE 2 project (2007-2013), and in
particular he is involved toghether with academic and administrative staff and students of the
university of Pavia in several work packages (01 MEDINE lingua, 02 Mobility Toolkit, 03
Tuning Process, 04 Bologna First Cycle, 05 Curriculum Trends, 06 Progressing Bologna, 07
Research, 08 Network management, 09 Dissemination of MEDINE2 outputs, 10 Exploitation of
MEDINE2 outputs, 11 Quality Assurance of the Network). The Network will investigate and
promote modern curriculum trends in medicine, through workshops across Europe, with
proceedings disseminated on-line. We will investigate and promote the Bologna Process as a
vehicle for educational enhancement in medical education. Obstacles will be evaluated,
solutions and examples of best practice will be identified and disseminated. As the responsible
for the International exchanges of the students of the Medical Faculty of the University of
Pavia, he is involved in the organization and practical carrying out of IFOM exams
(International Foundation of Medicine exam) for the students of our Faculty. He took care of
the development of all examination sessions performed until now. On the basis of this
supported exam offered to our students of the Faculty of Medicine, Dr Ricevuti in the referent
academic people for the GHLO project (Global Health Learning Opportunities) of the American
AAMC (Association of American Medical Colleges is a not-for-profit association representing all
133 accredited U.S. and 17 accredited Canadian medical schools) started on 2012 academic
year, that is involving only 21 Medicine Faculties of the world (8 from USA and 13 from the
rest of the world) and Pavia is only one from Italy. GHLO is AAMC’s new initiative that is a
network of collaborating institutions in over 16 countries, facilitating global mobility
for final year medical students pursuing clinical or research electives outside their home
country. GHLO utilizes a Web-based platform that enables students to search and apply for
electives, Home Schools to endorse student applications and track progress, and Host Schools
to manage the elective selection and evaluation processes. In 2013 he lauched two Interest
Group for students, EMIG EMERGENCY MEDICINE INTEREST GROUP and GerMedIn GERIATRIC
MEDDINE INTEREST GROUP to offer more information about didactical activities and research
projects and exchange or working possibilities in these topics. The groups are supported by the
CV Giovanni Ricevuti
1 10
hard work of some students and the information are posted on KIRO network of the University
of Pavia (http://lotarionline.unipv.it/moodle/course/category.php?id=55).
From 2014 he is the coordinator of the ALZMED PROJECT (Alzheimer in the Mediterranean
Coutries), research project of the Italian Ministry of Health.
After general medical training, he completed his training in internal medicine, haematology and cardiology at
I.R.C.C.S. Policlinico S. Matteo Hospital in Pavia. He obtained his Postgraduate Specializations in Internal
Medicine, Cardiovascular Diseases and Clinical and Laboratory Haematology at University of Pavia. He
worked at Nuclear Medicine Laboratory of the First Medical Clinic "Adolfo Ferrata" on physiopathology of red
blood cells and of platelets; then he organized his own Laboratory of Cellular Physiopathology and Clinical
Immunology of the Department of Internal Medicine and Therapeutics where he organized studies on
cellular immunology, on phagocytes, on neutrophils, adhesion molecules, complement and complement
receptors, cytokines and endothelial damage. Of particular interest he performed studies on the role of
neutrophils, oxy-radicals, adhesion molecules on endothelial damage and on pathogenesis of angina and
hearth ischaemia "in vivo" in humans with studies on blood from aorta and coronary sinus.
Dr Ricevuti also followed up his patients clinically and built up large series of patients with leukaemia,
lymphomas, tumors, familiar hypocomplementemia, hypo-CD4 syndrome and neutropenia. He is performing
researches on ATIII immune effects in collaboration with collegues from Austria and UK andf he is involved
in studies about pathogenesis and clinical and immunological aspects of Aging and Alzheimer Disease..
INTERNATIONAL COLLABORATIONS
-Department of Restorative Dentistry, University of Leeds UK.
-Department of Biology, University of Liverpool, UK.
-Dreyfus Medical Foundation, New York, USA.
-Department of Internal Medicine, University of Innsbruck, Austria.
-Department of Neuropathology, University of Liverpool, UK
-South Essex Partnership University NHS Foundation Trust (SEPT)
-AWARDS:
-
Fellowship from the Amministrazione Provinciale of Pavia (1965-1969)
National Prize LEPETIT (1971)
Fellowship from CECA. European Community (1971)
Fellowship from Italian University Ministry (1973, 1974)
National Prize SIDEV (1983)
National Prize "L. LIBERTI" (1985)
National Prize "L. LIBERTI" (1988)
TOPICS OF Dr. RICEVUTI'S RESEARCHES are:
1) PATHOPHYSIOLOGY OF WESSEL WALL AND TROMBOSIS
2) PATHOPHYSIOLOGY OF ANEMIA AND BONE MARROW APLASIA
3) ONCOLOGY AND HAEMATOLOGY
4) INFLAMMATORY REACTION
5) PATHOPHYSIOLOGY OF PHAGOCYTES
6) CYTOKINES AND ADHESION MOLECULES
7) PHAGOCYTE AND CORONARY ARTERY DISEASE
8) ATIII AND PHAGOCYTES AND PLATELETS
9) ALZHEIMER AND AGING
Dr Ricevuti presented comunications and gave lectures to several national and international Congresses,
and organized the"International Congress on The Biological and Clinical Aspects of Phagocyte Function",
Pavia, Italy, 1986, and the "2Nd International Congress on Phagocytes: Biological and Clinical Aspects",
September 1996, Pavia with Prof. Rodolfo Paoletti and prof. Antonia Notario, hosting the Nobel Prize Prof
Samuelsson
ADMINISTRATIVE RESPONSABILITIES: -Responsible of the Ambulatory of Clinical Immunology of the
Department of Internal Medicine and Therapeutics at the IRCCS Policlinico S.Matteo; member of the
Directive Council of the Department of Internal Medicine and Therapeutics of the university of Pavia from
1982 to 1985, from 1985 to 1989, from 1991 to 1994; from 1994 to 1998, from 1998 to 2002;
CV Giovanni Ricevuti
2 10
Administration of research founds from MURST 60% e 40% , Italian CNR, Dreyfus Medical Foundation in
New York, member of the Directive Council of the College of Physicians of the Province of Pavia, member of
the Commission for Internal Medicine of the Lombardy Country in Italy, member of the Council of the Italian
Society of Internal Medicine, Lombardy Country.
He is in the Editorial Board of the “International Journal of Immunopathology and Pharmacology”, indexed in
the Index Medicus, in the Current Contenst, Excerpta Medica database (EMBASE), BIOSIS, SUBIS. He served
as referee for several international journals such as Atherosclerosis, European Journal of Clinical
Investigation, Journal of Leukocyte Biology, Haematologica, Functional Neurology, International Journal of
Immunopharmacology, Biochemical Pharmacology, Circulation, and others.
Dr. Ricevuti is author or co-author of more than 500 publications, of which 300 papers and reviews in peerreviewed journal. He published some books or special issues on topics of immunology or phagocytes. The
last book has been published in 1997 on "Phagocytes" by New York Academy of Sciences with Proff. Rodolfo
Paoletti and Antonia Notario.
Qualification and recent results
Recently, he studied the molecular mechanism of hypocomplementemia and the pathogenetic role of
congenital and acquired hypocomplementemia in the development of immunomediated disease. He carried
out studies on cellular immunology, on phagocytes, adhesion molecules, complement and complement
receptors, cytokines and endothelial damage. He also carried out studies on the role of neutrophils, oxyradicals, adhesion molecules on endothelial damage and on the pathogenesis of angina and hearth
ischaemia "in vivo" in humans with studies on blood from aorta and coronary sinus. Dr Ricevuti also followed
up his patients clinically and built up large series of patients with leukaemia, lymphomas, tumors, familiar
hypocomplementemia, hypo-CD4 syndrome and neutropenia. His group has examined the functional aspects
of neutrophils in CAD patients before and after PTCA with the demonstration (one of the first observations in
humans) of the increase in the expression of neutrophil and monocyte adhesion molecules in unstable
coronary artery disease. He also showed the degranulation of PMNs releasing elastase and ROIs into
coronary vessels of patients suffering from atherosclerotic unstable angina. Recently he is studying the
effect of ATIII on neutrophil and platelet function in vitro and the immunologic alterations in patients
suffering from Alzheimer disease. Recently, the most important research topic is related to molecular and
morphofunctional aspects of Alzheimer disease and their modulation by TDCs and TMS. The interest is to
evaluate the efficacy of electromagnetic fields (EMFs) treatments in patients with Alzheimer's disease (AD)
and to identify related molecular pathways. In particular, the interest is oriented to molecular level towards
the identification of changes in the expression profiles of microRNAs (miRNAs) gene-regulatory sequences,
following EMFs exposure.
Papers of Prf Ricevuti have been cited in the following journals: -JAMA, -LANCET. –Circulation –
Inflammation, -Haematologica, -Journal of Leukocyte Biology, -Chinese Journal of Dermatology, -Journal of
Clinical Investigation, -New England Journal of Medicine, -European Journal of Clinical Investigation, -Journal
of American College of Cardiology, -International Journal of Immunopharmacology, -International Journal of
Immunopathology and Pharmacology.
SELECTED PUBLICATIONS
1. G: RICEVUTI, A: MAZZONE, M: DANESINO, M: TOSCANO, SC RIZZO
Phenytoin to prevent or control granulocyte transfusion reactions
The Lancet, 1984, 8392, II, 37
IF 16.135
2. RICEVUTI G.,BAIGUERA R., MAZZONE A., ROSSINI S.,FASANI F., TUMMINELLO M.C., PENSATO D.
Effects of phosphatidylserine on immunologic indices in aged patients.
Ann.N.Y.Acad.Sci.,496, 731 - 734,1987
3. RICEVUTI G., MAZZONE A., and HARLAN JM.
CV Giovanni Ricevuti
3 10
Membrane glycoproteins of neutrophils and related diseases
Haematologica , 73, 415 - 422,1988.
IF 2.560
4. RICEVUTI G., MAZZONE A., DE SERVI S.,FRATINO P.
New trends in coronary artery disease: the role of granulocyte activation.
Atherosclerosis 78, 261 - 265,1989.
IF 2.889
5. DE SERVI S., MAZZONE A., RICEVUTI G., FIORAVANTI A., BRAMUCCI E., ANGOLI L., GHIO S and
SPECCHIA G.
Granulocyte activation after Coronary angioplasty in human
Circulation, 82, 140-146, 1990
IF 15.202
6. RICEVUTI G., DE SERVI S., MAZZONE A., ANGOLI L., GHIO S. and SPECCHIA G.
Increased neutrophil aggregability in coronary artery disease
European Heart Journal 11, 814-818, 1990
IF 3.631
7. DE SERVI S., RICEVUTI G., MAZZONE A., PASOTTI D., BRAMUCCI E., ANGOLI L.,SPECCHIA G.
Transcardiac release of leukotriene C4 by neutrophils in patients with coronary artery disease.
J Am Coll Cardiology 17,1125-1128,1991
IF 14.09
8. MAZZONE A., DE SERVI S., RICEVUTI G., MAZZUCCHELLI I., FOSSATI G.L., PASOTTI D., BRAMUCCI
E., ANGOLI L., MARSICO F., SPECCHIA G., NOTARIO A.
Increased expression of neutrophil and monocyte adhesion mplecules in unstable coronary artery
disease.
Circulation, 1993; 88; 358-363
IF 15.202
9. S.DE SERVI, A.MAZZONE, G.RICEVUTI , G.FOSSATI, I.MAZZUCCHELLI, G.FOSSATI, D.GRITTI,
L.ANGOLI, G.SPECCHIA.
Clinical and angiographic correlates of leukocyte activation in unstable angina.
JACC 1995, Vol. 26 n° 5 : 1146-50.
IF 14.09
10. Mazzone, I.Mazzucchelli, G.Fossati, D.Gritti, M.Fea, G.Ricevuti. Granulocyte defects and opioid
receptors in chronic exposure to heroin or methadone in humans. Int.J.Immunopharmacol., 1994,
16: 959-67.
IF 4.092
11. A.Mazzone A., G. Ippoliti., G. Fossati., I. Mazzucchelli., P Abelli., D.Gritti, C. Canale., G. Randine and
G. Ricevuti. The CD11/CD18 Leu-CAM deficiency disease in a family with abnormal granulocyte fMLP
receptors. Int.J.Immunopath. and Pharm. 1994, 7: 163-182.
IF 4.092
12. S.De Servi, A.Mazzone, G.Ricevuti, G.Fossati, I.Mazzucchelli, G.Fossati, D.Gritti, L.Angoli, G.Specchia.
Clinical and angiographic correlates of leukocyte activation in unstable angina. JACC 1995, 25: 114650.
IF 14.09
13. A.Mazzone, I.Mazzucchelli, G.Fossati, D.Gritti, S.Girola, C.Canale, C.Cusa, and G.Ricevuti. Iloprost
effect on phagocytes in patient suffering from ischaemia disease: in vivo evidence for down26: 860-866.
IF 3.365
14. A.Mazzone, C.Porta, G.Fossati, D.Gritti, I.Mazzucchelli and G.Ricevuti. Granulocyte dysplasia and
dysfunction, and CD11/CD18 defects in Myelodysplastic Syndromes. Leukemia and Lymphoma 1996,
23: 267-275
15. A.Mazzone, I.Mazzucchelli, G.Fossati, D.Gritti, C.Canale, C.Cusa, and G.Ricevuti. Increased
expression of
2 integrin onphagocytes in ischemic disease: a bridge between inflammation and
coagulation system. Eur.J.Clin.Invest. 1997, 27: 648-652.
IF 3.365
CV Giovanni Ricevuti
4 10
16. A.Novella, G.Bergamaschi, C.Canale, G.Fossati, D.Gritti, C.Luccotti, A.Mazzone, L.Tanon and
M.Cazzola. Expression of adhesion molecules and functional stimulation in human neutrophils:
modulation by GM-CSF and role of the Bcr gene. Brith J Haematol 1997, 98: 621-626. IF=2.815
17. C.Canale, G.Fossati, I.Mazzucchelli, D.Gritti, M.Celano, S.Girola, A.Mazzone. Flow cytometry assay of
phagocyte integrins in ischemic diseases. Europ.J.Histochem. 1997, 41/suppl.2; pp.7-8. IF=0.959
18. G.Ricevuti, I.Mazzucchelli, D.Gritti, C.Canale,C.Pistone, M.Intili, M.Montagna, G.Fossati.. Over
expressionof Mﬂ2 integrin on pheripheral blood human neutrophis stimulated with GM-CSF.
Europ.J.Histochem. 1997, 41/suppl.2; pp.41-42. IF=0.959
19. R.Paoletti, A.Notario, G.Ricevuti. (Editors). Phagocytes: Biology, physiology, pathology and
pharmacology. Annals of the New York Academy of Sciences, Volume 832, New York 1997
20. G.Ricevuti. Host Tissue Damage by Phagocytes. In Phagocytes: Biology, physiology, pathology and
pharmacology. Annals of the New York Academy of Sciences, Volume 832, pp 426-448, New York
1997
21. G.Fossati, I.Mazzucchelli, D.Gritti, G.Ricevuti, S.W.Edwards, D.A.Moulding and M.L.Rossi. In vitro
effects of GM-CSF on mature peripheral blood neutrophils. Int.J.Mol.Med. 1998, 1: 943-951. IF 2
22. QUATTRINI, R. NEMNI, B. SFERRAZZA, G. RICEVUTI, G. DELL'ANTONIO, A. LAZZERINI, S.
IANNACONE.
Amyloid neuropathy simulating lower motor neuron disease.
Neurology, 51:600-602, 1998
IF 4.972
23. G: KOOPMAN, T: E: I: TAHER, I: MAZZUCCHELLI, R: M., J: KEEHNEN, R: VAN DER VORT, E:
MANTEN-HORST, G: RICEVUTI, S: T: PALS, P:K: DAS
CD44 isoforms, including the CD44v3 variant, are expressed on endothelium, suggesting a role for
CD44 in the immobilization of growth factors and the regulation of the local immune response.
Biochem Biophys Res Com, 1998, 245, 172-176
IF 2.780
24. G.RICEVUTI
Free radicals in gliomas: friend or foes
25. Eur J. Clin. Invest, 1998, febbraio
IF 3.365
26. G. FOSSATI, G. RICEVUTI, S.T. EDWARDS. C. WALKER, A. DALTON, M.L. ROSSI
Neutrophil infiltration into human gliomas
Acta Neuropathol. , 1999, 98, 349-354
IF 2.336
27. G.Ricevuti. Free radicals in gliomas: friends or foes? Eur J Clin Invest. 29: 185-188, 1999. IF=2.255.
28. Fossati G, Ricevuti G, Edwards SW, Walker C, Dalton A, Rossi ML. Neutrophil infiltration into human
gliomas. Acta Neuropathol (Berl) 1999 Oct;98(4):349-54. IF=2.165.
29. Norbert Reinisch, Christian J. Wiedermann, Giovanni Ricevuti. Impaired human pripheral blood
neutrophil respiratory burst by alcohol-based venipuncture site disinfection. Clin Diagn Lab Immunol,
2000, 7, 980-982. IF=1.809.
30. T. Buratti, M Herold, FJ Wiedermann, G Ricevuti and CJ Wiedermann. Biological markers of left
ventricular
dysfunction
in
septic
shock.
Clin
Chem
(2000),
e-letter:
www.clinchem.org./cgi/eletters/46/50/650. IF=4.371.
31. T Buratti, G Ricevuti, C Pechlaner, M Joannidis, FJ Wiedermann, D Gritti, M Herold and CJ
Wiedermann. Plasma level of procalcitonin and interleukin-6 in acute miocardial infarction.
Inflammation 2001, 25: 97-100.
IF=1.643.
CV Giovanni Ricevuti
5 10
32. CM Reinisch, S Dunzendorfer, C Pechlaner, G Ricevuti and CJ Wiedermann. The inhibition of oxigen
radical release from human neutrophils by resting platelets is reversed by administration of
acetylsalicylic acid or clopidogrel. Free Rad Res 2001, 34: 461-466.
IF=2.735.
33. Giovanni Ricevuti and Christian J. Wiedermann. Immune Activation Augments Infection-dependent
Atherogenesis. In: Shoenfeld Y, Haratz D, Wick G (eds). Atherosclerosis and autoimmunity.
Amsterdam, The Netherlands: Elsevier Publishing House, 2001.
34. G.Ricevuti, D.Gritti, C.Gasparetto and C.J.Wiedermann. Immune activation as effect modifier of
atherogenesis in chronic infection. Int Rev Immunol 2002, 21:27-31
IF 1.868
35. Donatella Gritti, Chiara Gasparetto, Angela Malinverno, and Giovanni Ricevuti. Inhibition of
Leukocyte and Platelet Aggregation in vitro by Antithrombin. Acta Medica Austriaca 2002, 29:97-99.
IF=0.287.
36. Keneider NC, Egger P, Dunzerdorfen S, Noris P, Balduini CL, Gritti D, Ricevuti G, Wiedermann CJ.
Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA
reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism. Arterioscler
Thromb Vasc Biol. 2002 Jun 1;22(6):894-900.
IF=7.432.
37. Marchioni E, Ceroni M, Erbetta A, Alfonsi E, Bottanelli M, Imbesi F, Ricevuti G. Severe acute
cerebrovascular disease revealing hepatitis C virus infection: effectiveness of alpha-interferon. J
Neurol. 2002 Aug;249(8):1111-3. IF=2.653.
38. Kaneider NC, Kaser A, Tilg H, Ricevuti G, Wiedermann CJ. CD40 ligand-dependent maturation of
human monocyte-derived dendritic cells by activated platelets. Int . J. Immunopathol. Pharmacol.
2003 Sep-Dec;16(3):225-31.
IF=4.092.
39. Gritti D., Malinverno A., Gasparetto C., C.J. Wiedermann C.J. * and Ricevuti G. Attenuation of
leukocyte (Beta)2-integrin expression by antithrombin-III.
International Journal of Immunopathology and Pharmacology. Vol. 17, no. 1, 27-32 (2004).
IF=4.092..
40. Lorusso L, Hart IK, Giometto B, Pezzani R, Broome JC, Gritti D, Gasparetto C, Ricevuti G.
Immunological features of neurological paraneoplastic syndromes. Int J Immunopathol Pharmacol.
2004 May-Aug;17(2):135-144
41. Zorzetto M, Ricevuti G, Martinetti M, Gritti D, Gasparetto C, De Silvestri A, Salvaneschi L, Cuccia M.
HLA and hypocomplementemia: the disadvantage of carrying the HLA-B35 and the silent alleles of
the C4 complement component.
Int J Immunopathol Pharmacol. 2004 Sep-Dec;17(3):307-16.
IF=4.092
42. BENZONI E, TORRE ML, FAUSTINI M, STACCHEZZINI S, CREMONESI F, CONTE U, VILLANI S,
RUSSO V, RICEVUTI G., VIGO D. (2005). Transient transfection of porcine granulosa cells after 3D
culture in barium alginate capsules. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND
PHARMACOLOGY. vol. 18, pp. 677-682 ISSN: 0394-6320.
IF 4.092.
43. GASPARETTO C, MALINVERNO A, CULACCIATI D, GRITTI D, PROSPERINI PG, SPECCHIA G,
RICEVUTI G. (2005). Antioxidant vitamins reduce oxidative stress and ventricular remodeling in
patients with acute myocardial infarction. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND
PHARMACOLOGY. vol. 18, pp. 487-496 ISSN: 0394-6320.
IF 4.092.
44. KANEIDER NC, FEISTRITZER C, GRITTI D, MOSHEIMER BA, RICEVUTI G., PATSCH JR,
WIEDERMANN CJ. (2005). Expression and function of syndecan-4 in human platelets. THROMBOSIS
AND HAEMOSTASIS. vol. 93, pp. 1120-1127 ISSN: 0340-6245.
IF 5.138
45. NGONGA GF, FERRARI D, LORUSSO L, GASPARETTO C, NEZNAMA E, D'ABRAMO M, RICEVUTI G.
(2005). Paraneoplastic syndromes: pathogenetic theories, clinical aspects and therapeutic approach.
ANNALI ITALIANI DI MEDICINA INTERNA. vol. 20, pp. 28-38 ISSN: 0393-9340.
46. BIRGIT MOSHEIMER, NICOLE C KANEIDER, CHRISTOPHER R ROSS, RICEVUTI G., JOSEF R
PATSCH, CHRISTIAN J WIEDERMANN. (2006). Heparan sulfate proteoglycan-dependent neutrophil
CV Giovanni Ricevuti
6 10
chemotaxis toward PR-39 cathelicidin. JOURNAL OF INFLAMMATION. vol. 3:14 ISSN: 1078-7852. IF
2.14
47. RICEVUTI G., GASPARETTO C. (2006). Bioethics, the Surviving Sepsis Campaign, and the industry.
WIENER KLINISCHE WOCHENSCHRIFT. vol. 118, pp. 65 ISSN: 0043-5325.
IF 0.65
48. LORUSSO L, HART IK, FERRARI D, NGONGA GK, GASPARETTO C, RICEVUTI G. (2007). Autonomic
paraneoplastic neurological syndromes. AUTOIMMUNITY REVIEWS. vol. 6, pp. 161-168 ISSN: 15689972.
IF 7.965
49. ROSS CR, RICEVUTI G., SCOVASSI AI. (2007). The antimicrobial peptide PR-39 has a protective
effect against HeLa cell apoptosis. CHEMICAL BIOLOGY & DRUG DESIGN. vol. 70, pp. 154-157
ISSN: 1747-0277. IF 1.720
50. BIRGIT MOSHEIMER, NICOLE C KANEIDER, CHRISTOPHER R ROSS, RICEVUTI G., JOSEF R
PATSCH, CHRISTIAN J WIEDERMANN. (2006). Heparan sulfate proteoglycan-dependent neutrophil
chemotaxis toward PR-39 cathelicidin. JOURNAL OF INFLAMMATION. vol. 3:14 ISSN: 1078-7852.
IF 2.14
51. RICEVUTI G., GASPARETTO C. (2006). Bioethics, the Surviving Sepsis Campaign, and the industry.
WIENER KLINISCHE WOCHENSCHRIFT. vol. 118, pp. 65 ISSN: 0043-5325.
IF 0.65
52. LORUSSO L, HART IK, FERRARI D, NGONGA GK, GASPARETTO C, RICEVUTI G. (2007). Autonomic
paraneoplastic neurological syndromes. AUTOIMMUNITY REVIEWS. vol. 6, pp. 161-168 ISSN: 15689972.
IF 7.965
53. ROSS CR, RICEVUTI G., SCOVASSI AI. (2007). The antimicrobial peptide PR-39 has a protective
effect against HeLa cell apoptosis. CHEMICAL BIOLOGY & DRUG DESIGN. vol. 70, pp. 154-157
ISSN: 1747-0277.
IF 1.720
54. Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of
chronic fatigue syndrome. Autoimmun Rev. 2009 Feb;8(4):287-91. Epub 2008 Sep 16.
IF 7.965
55. L. Venturini,*,_ C. Osera,_ A. Pascale,_ M. Amadio,_ F. Sardi,*,_ M. Mainardi,*,_ S. Govoni,_ & G.
Ricevuti
Lowered immune system reactivity as a feature of Alzheimer Disease patients with
hypocomplementemia
Immunology (2010), 131, pag 190,
Impact Factor: 3.276
56. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR,
Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rtPA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW,
Barber PA, Levi C, Bladin C, Byrnes G. Ricevuti G.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of
ECASS, ATLANTIS, NINDS, and EPITHET trials.
Lancet. 2010 May 15;375(9727):1695-703
Impact Factor: 30.758
57. Tavazzi E, Bargiggia V, Pichiecchio A, Delbue S, Maserati R, Bastianello S, Ferrante P, Minoli L,
Ricevuti G, Ceroni M, Marchioni E.
HIV-related acute inflammatory leukoencephalopathy of undetermined origin: review of the
literature.
Int J Immunopathol Pharmacol. (2010); 23(3):693-700
IF:4.092
58. E. CAPELLI, R. ZOLA, L. LORUSSO, L. VENTURINI, F. SARDI and G. RICEVUTI
CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS: AN UPDATE
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
CV Giovanni Ricevuti
7 10
Vol. 23, no. 3, 0-0 (2010)
IF:4.092
59. Osera C, Fassina L, Amadio M, Venturini L, Buoso E, Magenes G, Govoni S, Ricevuti G, Pascale A.
Cytoprotective Response Induced by Electromagnetic Stimulation on SH-SY5Y Human
Neuroblastoma Cell Line.
Tissue Eng Part A. 2011 Jul 5
IF: 5.444
60. Chiara Boiocchi 1, Elisa Maggioli 1, Giovanni Ricevuti 2, Stella Gagliardi 3, Cristina Cereda 3, Mariaclara
Cuccia 1
1
University of Pavia, Pavia, Italy - 2IDR S. Margherita, University of, Pavia, Italy - 3IRCCS Fondazione
“Istituto Neurologico C.Mondino, Pavia, Italy
AN HAPLOTYPIC STUDY OF HLA CLASS III GENE POLYMORPHISMS IN ALZHEIMER DISEASE ,
Abstract for the 25th European Immunogenetics and Histocompatibility Conference (EFI)
61. Functional immunogenetics: from basic mechanisms to clinical implications
Boiocchi C, Maggioli E, Cereda C, Ricevuti G, Cuccia M
BC, ME and CM Immunogenetics Laboratory, Department of Genetics and Microbiology, University of
Pavia; CC Laboratory of Experimental Neurobiology, IRCCS Foundation Istituto Neurologico C.
Mondino, University of Pavia; RG Department of Internal Medicine and Gerontology, IDR S.
Margherita, University of
Pavia., Convegno Congiunto IGM-DGM, 22-23 Febbraio 2011
62. Enzo Emanuele1, Valentina Martinelli1, Vera Abbiati1, Giovanni Ricevuti2,3
Linking atherosclerosis to Alzheimer’s disease: focus on biomarkers
Frontiers in Bioscience, in press 2011
63. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly.
Sardi F, Fassina L, Venturini L, Inguscio M, Guerriero F, Rolfo E, Ricevuti G.
Autoimmun Rev. 2011 Oct 5
IF 7.965
63) Brain-derived neurotrophic factor gene (BDNF) variants and Alzheimer's disease: an association
study in an AD Italian population. Boiocchi C, Maggioli E, Zorzetto M, Sinforiani E, Cereda C,
Ricevuti G, Cuccia M., Rejuvenation Res. 2012 Dec 6.
64)
Comparison between the AA/EPA ratio in depressed and non depressed elderly females:
omega-3 fatty acid supplementation correlates with improved symptoms but does not change
immunological parameters., Rizzo AM, Corsetto PA, Montorfano G, Opizzi A, Faliva M, Giacosa A,
Ricevuti G, Pelucchi C, Berra B, Rondanelli M., Nutr J. 2012 Oct 10;11:82. doi: 10.1186/14752891-11-82.
65)
3.Alzheimer disease and platelets: how's that relevant., Catricala' S, Torti M, Ricevuti G.,
Immun Ageing. 2012 Sep 17;9(1):20.
66)
4.Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's
disease., Verri M, Pastoris O, Dossena M, Aquilani R, Guerriero F, Cuzzoni G, Venturini L,
Ricevuti G, Bongiorno AI., Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):345-53.
Review.
IF:4.092
67)
5.Linking atherosclerosis to Alzheimer's disease: focus on biomarkers., Emanuele E,
Martinelli V, Abbiati V, Ricevuti G., Front Biosci (Elite Ed). 2012 Jan 1;4:700-10. Review.
68)
6.Pentraxins and Alzheimer's disease: at the interface between biomarkers and
pharmacological targets., Osera C, Pascale A, Amadio M, Venturini L, Govoni S, Ricevuti G.,
Ageing Res Rev. 2012 Apr;11(2):189-98. doi: 10.1016/j.arr.2011.12.004. Epub 2011 Dec 15.
Review.
CV Giovanni Ricevuti
8 10
69) Comparison between the AA/EPA ratio in depressed and non depressed elderly
females: omega-3 fatty acid supplementation correlates with improved symptoms but
does not change immunological parameters.
70) Rizzo AM, Corsetto PA, Montorfano G, Opizzi A, Faliva M, Giacosa A, Ricevuti G,
Pelucchi C, Berra B, Rondanelli M.
Nutr J. 2012 Oct 10;11:82. doi: 10.1186/1475-2891-11-82.
Alzheimer disease and platelets: how's that relevant.
Catricala S, Torti M, Ricevuti G.
71)
Immun Ageing. 2012 Sep 17;9(1):20. doi: 10.1186/1742-4933-9-20.
72)
Mitochondrial alterations, oxidative stress and neuroinflammation in
Alzheimer's disease.
Verri M, Pastoris O, Dossena M, Aquilani R, Guerriero F, Cuzzoni G, Venturini
L, Ricevuti G, Bongiorno AI.
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):345-53. Review.
Linking atherosclerosis to Alzheimer's disease: focus on biomarkers.
Emanuele E, Martinelli V, Abbiati V, Ricevuti G.
73)
Front Biosci (Elite Ed). 2012 Jan 1;4:700-10. Review.
The human leukocyte antigen class III haplotype approach: new insight in
Alzheimer's disease inflammation hypothesis.
Maggioli E, Boiocchi C, Zorzetto M, Sinforiani E, Cereda C, Ricevuti G, Cuccia M.
74)
Curr Alzheimer Res. 2013 Dec;10(10):1047-56.
Association of the K153R polymorphism in the myostatin gene and extreme
longevity.
Garatachea N, Pinós T, Cámara Y, Rodríguez-Romo G, Emanuele E, Ricevuti G, Venturini
L, Santos-Lozano A, Santiago-Dorrego C, Fiuza-Luces C, Yvert T, Andreu AL, Lucia A.
75)
Age (Dordr). 2013 Dec;35(6):2445-54. doi: 10.1007/s11357-013-9513-3. Epub 2013 Jan 25.
76)
Brain-derived neurotrophic factor gene variants and Alzheimer disease: an
association study in an Alzheimer disease Italian population.
Boiocchi C, Maggioli E, Zorzetto M, Sinforiani E, Cereda C, Ricevuti G, Cuccia M.
Rejuvenation Res. 2013 Feb;16(1):57-66. doi: 10.1089/rej.2012.1381.
77)
Autophagy Is Modulated in Human Neuroblastoma Cells Through Direct Exposition
to Low Frequency Electromagnetic Fields.
Marchesi N, Osera C, Fassina L, Amadio M, Angeletti F, Morini M, Magenes G,
Venturini L, Biggiogera M, Ricevuti G, Govoni S, Caorsi S, Pascale A, Comincini S.
J Cell Physiol. 2014 Mar 27. doi: 10.1002/jcp.24631. [Epub ahead of print]
78)
.ApoE gene and exceptional longevity: Insights from three independent cohorts.
CV Giovanni Ricevuti
9 10
Garatachea N, Emanuele E, Calero M, Fuku N, Arai Y, Abe Y, Murakami H, Miyachi M,
Yvert T, Verde Z, Zea MA, Venturini L, Santiago C, Santos-Lozano A, Rodríguez-Romo
G, Ricevuti G, Hirose N, Rábano A, Lucia A.
Exp Gerontol. 2014 May;53:16-23. doi: 10.1016/j.exger.2014.02.004. Epub 2014 Feb 15.
CV Giovanni Ricevuti
10 10

Download Report